The Patent Finder

Terms ending in 2032

ImmunoGen, Inc.

Every in-force patent on ImmunoGen, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,889,669Cytotoxic Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 9,169,272Cytotoxic Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 9,840,564Cytotoxic Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,179,818Cytotoxic Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US RE49,918Cytotoxic Benzodiazepine Derivatives
In force
 · Low confidence
ImmunoGen, Inc.In forceLow confidence
US 9,156,854Novel Maytansinoid Derivatives with Sulfoxide Linker
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 9,428,543Preparation of Maytansinoid Antibody Conjugates by a One-Step Process
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 10,435,432Preparation of Maytansinoid Antibody Conjugates by a One-Step Process
In force
 · High confidence
ImmunoGen Inc.In forceHigh confidence
US 11,744,900Preparation of Maytansinoid Antibody Conjugates by a One-Step Process
In force
 · High confidence
ImmunoGen Inc.In forceHigh confidence
US 8,709,432Methods for Increasing Efficacy of FOLR1 Cancer Therapy
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
5 more term ends in 2032 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Upgrade to Pro
13 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited